Next Financial Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Next Financial Group's DGX Position: Q4 2021 in Review
Next Financial Group reduced its Quest Diagnostics (DGX) stake by 34% in Q4 2021, selling an estimated $133K and leaving 1,707 shares worth $295K. The position accounts for 0.02% of the portfolio, ranked #737.
Next Financial Group first reported a position in DGX in Q3 2014 and has held it in 27 quarters since. The position peaked at $543K in Q1 2021. 905 funds tracked by Wall St. Rank hold DGX as of Q4 2021.
- Next Financial Group held 1,707 shares of Quest Diagnostics worth $295K as of Q4 2021.
- Next Financial Group sold 877 Quest Diagnostics shares in Q4 2021, an estimated $133K.
- Quest Diagnostics made up 0.02% of Next Financial Group's portfolio in Q4 2021, its #737 holding.
- Next Financial Group first reported a position in Quest Diagnostics in Q3 2014 and has held it in 27 quarters since.
- Next Financial Group's Quest Diagnostics position peaked at $543K in Q1 2021.
- 905 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2021.
Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.